# US 2025/0082673 A1 · Colon lavage system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082673 A1
- Document ID: US20250082673A1
- Status: Published application
- Kind: A1
- Application number: 18/657,428
- Filed: 2024-05-07
- Published: 2025-03-13
- Earliest claimed: 2009-04-21
- Assignees: Dark Canyon Laboratories, LLC
- Applicants: Dark Canyon Laboratories, LLC
- Inventors: Dale R. Bachwich
- Web page: https://patentgrep.com/patent/US20250082673A1

## CPC

- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A23L 27/88: {Taste or flavour enhancing agents}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 9/4808: {characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084)}
- A61K 9/50: Microcapsules {having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals (A61K9/2081 takes precedence; particles with a single coating comprising drug A61K9/167)}
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/77: of oxiranes
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61P 1/10: Laxatives
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides compositions, systems, kits, and methods for preparation prior to a colonoscopy or other gastrointestinal procedure. In particular, the present invention provides a colon lavage system comprising an aqueous portion and a solid portion.

## Claims

### Claim at position 1

-28. (canceled)

### Claim 29

A method for preparing for a colon-related procedure comprising:
a) orally administering an osmotic agent dose dissolved in water;
b) orally administering one or more of a plurality of electrolyte doses, wherein said electrolyte doses are administered in a pill, capsule, tablet, or gel-cap form; and
c) repeating steps (a) and (b) one or more times.

### Claim 30 (depends on 29)

The method of claim 29, wherein the osmotic agent is PEG having average molecular weight between 2000 and 8000.

### Claim 31 (depends on 29)

The method of claim 29, wherein the osmotic agent is PEG 3350.

### Claim 32 (depends on 29)

The method of claim 29, wherein the electrolytes are independently selected from the group consisting of sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride, magnesium sulfate, magnesium citrate, ascorbic acid, and sodium ascorbate.

### Claim 33 (depends on 29)

The method of claim 29, wherein the electrolytes are independently selected from the group consisting of sodium bicarbonate, sodium chloride, and potassium chloride.

### Claim 34 (depends on 29)

The method of claim 29, wherein the electrolyte dose comprises: from 0.2 g to 20 g sodium chloride; from 0.1 g to 5 g potassium chloride; and from 0.1 g to 10 g sodium bicarbonate.

### Claim 35 (depends on 34)

The method of claim 34, further comprising from 0.1 g to 40 g sodium sulfate.

### Claim 36 (depends on 29)

The method of claim 29, wherein the electrolyte dose comprises from 1 g to 2 g sodium chloride; from 0.1 g to 0.3 g potassium chloride; and from 0.5 g to 1 g sodium bicarbonate.

### Claim 37 (depends on 30)

The method of claim 30, wherein a dose of PEG is from 25 g to 100 g.

### Claim 38 (depends on 37)

The method of claim 37, wherein the dose of PEG is from 25 g to 35 g.

### Claim 39 (depends on 38)

The method of claim 38, wherein the dose of PEG is from 50 g to 60 g.

### Claim 40 (depends on 29)

The method of claim 29, further comprising the step of passing stool from the colon of the subject.

### Claim 41 (depends on 40)

The method of claim 40, further comprising the step of analyzing said stool.

### Claim 42 (depends on 29)

The method of claim 29, further comprising the step of performing a diagnostic or surgical procedure on said subject.

### Claim 43 (depends on 29)

The method of claim 29, further comprising the step of receiving a colon-related or gastrointestinal medical procedure.

### Claim 44 (depends on 43)

The method of claim 43, wherein said colon-related or gastrointestinal medical procedure comprises colonoscopy.

### Claim 45 (depends on 43)

The method of claim 43, wherein said colon-related or gastrointestinal medical procedure comprises capsule endoscopy, balloon enteroscopy, endoluminal gastroplication, endoscopic ultrasound (EUS), esophagogastroduodenoscopy (EGD), endoscopic retrograde cholangiopancreatography (ERCP), esophageal pH exam, flexible sigmoidoscopy (Flex Sig), hydrogen breath test, liver biopsy, percutaneous endoscopic gastrostomy (PEG), biofeedback for anorectal dysfunction, intraoperative radiation therapy (IORT), diagnostic GI radiology, CT colonography, CT enterography, MR colonography, MR enterography, laparoscopic cholecystectomy, colectomy, hysterectomy, hemorrhoidectomy, herniorrhaphy, or NOTES (natural orifice transluminal endoscopic surgery).
